Hypertriglyceridemia and cardiovascular risk reduction
- PMID: 17697898
- DOI: 10.1016/j.clinthera.2007.05.002
Hypertriglyceridemia and cardiovascular risk reduction
Abstract
Background: Elevated triglyceride (TG) levels are prevalent among the US population, often occurring in persons who are overweight or obese, or who have type 2 diabetes or the metabolic syndrome. There is evidence that elevated TG levels may be a significant independent risk factor for coronary heart disease (CHD), particularly in women.
Objective: This article reviews data on the epidemiology, associated risks, treatment, and prevention of hypertriglyceridemia, including recommended TG goals and available TG-lowering agents.
Methods: MEDLINE was searched for articles published from 1990 through 2006 using the terms hypertriglyceridemia, dyslipidemia, and coronary heart disease, with subheadings for risk, statins, niacin, fibrates, thiazolidinediones, and omega-3 fatty acids. The reference lists of relevant articles were examined for additional citations. Publications discussing the epidemiology of hypertriglyceridemia, CHD risk, treatment guidelines for lipid management, clinical trials involving TG-lowering drugs, and outcomes for lipid-modifying therapies were selected for review.
Results: Concern over the increasing rate of hypertriglyceridemia and its deleterious health consequences is reflected in the most recent National Cholesterol Education Program guidelines. Several lipid-lowering agents are available, including statins, fibrates, niacin, thiazolidinediones, and prescription omega-3 fatty acids. Clinical trials of these drugs have reported lowering of TG by 7% to 50%. Along with lifestyle changes, the use of combination pharmacotherapy to reduce lipid levels (including TG) may be an effective strategy in patients with dyslipidemia.
Conclusion: Use of strategies to manage TG levels, along with low-density lipoprotein cholesterol levels, is warranted to help reduce the risk of CHD.
Similar articles
-
Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.Curr Med Res Opin. 2001;17(1):60-73. Curr Med Res Opin. 2001. PMID: 11464448 Review.
-
Optimal management of combined dyslipidemia: what have we behind statins monotherapy?Adv Cardiol. 2008;45:127-153. doi: 10.1159/000115192. Adv Cardiol. 2008. PMID: 18230960 Review.
-
TRIGLYCERIDES, ATHEROSCLEROSIS, AND CARDIOVASCULAR OUTCOME STUDIES: FOCUS ON OMEGA-3 FATTY ACIDS.Endocr Pract. 2017 Jan;23(1):100-112. doi: 10.4158/EP161445.RA. Epub 2016 Nov 7. Endocr Pract. 2017. PMID: 27819772 Review.
-
Hypertriglyceridemia-why, when and how should it be treated?Z Kardiol. 2005 Nov;94(11):731-9. doi: 10.1007/s00392-005-0295-1. Z Kardiol. 2005. PMID: 16258774 Review.
-
Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.J Manag Care Pharm. 2008 Oct;14(8 Suppl):S3-28; quiz S30-1. J Manag Care Pharm. 2008. PMID: 19891279 Review.
Cited by 33 articles
-
Lime (Citrus aurantifolia (Christm.) Swingle) Essential Oils: Volatile Compounds, Antioxidant Capacity, and Hypolipidemic Effect.Foods. 2019 Sep 7;8(9):398. doi: 10.3390/foods8090398. Foods. 2019. PMID: 31500259 Free PMC article.
-
Antidiabetic and Antihyperlipidemic Activities of the Leaf Latex Extract of Aloe megalacantha Baker (Aloaceae) in Streptozotocin-Induced Diabetic Model.Evid Based Complement Alternat Med. 2019 Apr 23;2019:8263786. doi: 10.1155/2019/8263786. eCollection 2019. Evid Based Complement Alternat Med. 2019. PMID: 31178917 Free PMC article.
-
Heat stability of the in vitro inhibitory effect of spices on lipase, amylase, and glucosidase enzymes.Food Sci Nutr. 2019 Jan 28;7(2):425-432. doi: 10.1002/fsn3.797. eCollection 2019 Feb. Food Sci Nutr. 2019. PMID: 30847119 Free PMC article.
-
Skeletal Muscle Acute and Chronic Metabolic Response to Essential Amino Acid Supplementation in Hypertriglyceridemic Older Adults.Curr Dev Nutr. 2017 Oct 17;1(11):e002071. doi: 10.3945/cdn.117.002071. eCollection 2017 Nov. Curr Dev Nutr. 2017. PMID: 29955688 Free PMC article.
-
Non-fasting triglyceride levels in the Korean population with and without ischemic heart disease and cerebrovascular disease.Korean J Intern Med. 2019 Mar;34(2):353-364. doi: 10.3904/kjim.2016.285. Epub 2017 Nov 15. Korean J Intern Med. 2019. PMID: 29132199 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
-
Full Text Sources
-
Other Literature Sources
-
Medical
-
Miscellaneous